High serum levels of CD178 (soluble FasL) predict for inferior progression free survival in chronic lymphocytic leukemia treated with fludarabine-based chemotherapy. Issue 10 (24th August 2019)

Record Type:
Journal Article
Title:
High serum levels of CD178 (soluble FasL) predict for inferior progression free survival in chronic lymphocytic leukemia treated with fludarabine-based chemotherapy. Issue 10 (24th August 2019)
Main Title:
High serum levels of CD178 (soluble FasL) predict for inferior progression free survival in chronic lymphocytic leukemia treated with fludarabine-based chemotherapy
Authors:
Tate, Courtney
Burgess, Melinda
McMillan, Nigel A.
Saunders, Nicholas A.
Cheung, Catherine
Gill, Devinder
Mollee, Peter
Abstract:
Is Part Of:
Leukemia & lymphoma. Volume 60:Issue 10(2019)
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 10(2019)
Issue Display:
Volume 60, Issue 10 (2019)
Year:
2019
Volume:
60
Issue:
10
Issue Sort Value:
2019-0060-0010-0000
Page Start:
2563
Page End:
2567
Publication Date:
2019-08-24
Subjects:
Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:
http://informahealthcare.com ↗
DOI:
10.1080/10428194.2019.1581936 ↗
Languages:
English
ISSNs:
1042-8194
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
18562.xml